ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neuromusculoskeletal Medicine, Sports Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,892Medicare Part D Prescriptions Filled, Including Refills
$405K Total Retail Price of All Prescriptions
216 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 427 196
METFORMIN HCL 242 148
LEVOTHYROXINE SODIUM 211 159
SIMVASTATIN 186 98
TRAMADOL HCL 175 59
LOVASTATIN 170 84
CITALOPRAM HBR 165 108
GABAPENTIN 162 100
POTASSIUM CHLORIDE 148 122
LISINOPRIL 134 77
FUROSEMIDE 130 83
CEFUROXIME 130 81
GLIMEPIRIDE 117 86
AMLODIPINE BESYLATE 114 49
CLOPIDOGREL 107 57
THEOPHYLLINE ANHYDROUS 107 41
QUETIAPINE FUMARATE 104 52
SERTRALINE HCL 100 22
SUCRALFATE 98 38
CYCLOBENZAPRINE HCL 93 16 R
AZITHROMYCIN 89 51
METOPROLOL TARTRATE 84 63
ALENDRONATE SODIUM 84 63
HYDROXYZINE HCL 82 21 R
FENOFIBRATE 82 42
HYDROCHLOROTHIAZIDE 82 66
WARFARIN SODIUM 80 45
FINASTERIDE 80 55
PLAVIX 73 36
MELOXICAM 72 35
CARVEDILOL 69 32
SPIRONOLACTONE 68 16
DEXAMETHASONE 63 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 43
DILTIAZEM 24HR ER 62 35
OXYBUTYNIN CHLORIDE 58 30
RANITIDINE HCL 53 25
DILTIAZEM HCL 53 49
KLOR-CON M10 53 34
ALLOPURINOL 51 37
PRAMIPEXOLE DIHYDROCHLORIDE 51 40
ROPINIROLE HCL 51 19
DICLOFENAC SODIUM 51 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.